Biologics in COPD Why, When, and Who

Dr. Jamie Rutland discusses the role of biologic therapy in COPD on our June episode of the APAPP podcast.
He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients.
Learn more about the APAPP podcast here: www.pulmapp.co...